Jun. 27 at 5:01 PM
$DOCN This is a solid investment regardless of what seems like a sideways slog over the last couple of months.
Just extremely undervalued. The company's cash on balance sheet is 14% of their entire market cap. That means they could extinguish 10% of their outstanding shares in buybacks and still have money left over.
The track history on this one though is ugly versus the S&P 500 over the last 3 years. But, I imagine retail investors fail to see why that is. Turn-a-round story stocks are difficult to get excited about until the full story takes shape.
